Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BLENREP safely and effectively. See full prescribing information for BLENREP.BLENREP (belantamab mafodotin-blmf) for injection, for intravenous useInitial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
BLENREP is indicated in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy, including a proteasome inhibitor and an immunomodulatory agent.
- generic_name
- belantamab mafodotin
- product_names
- belantamab mafodotin
- ndc
- 0173-0913, 0173-0913-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en